<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Lorazapam</id>
	<title>Lorazapam - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Lorazapam"/>
	<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Lorazapam&amp;action=history"/>
	<updated>2026-08-17T09:23:39Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Lorazapam&amp;diff=27735&amp;oldid=prev</id>
		<title>Mfrdmanager: Created page with &quot;====Lorazapam (ATIVAN) / Sedative Hypnotic==== '''DESCRIPTION''' * It is a skeletal muscle relaxant that reduces tremors, induces amnesia, and reduces the incidence and recurr...&quot;</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Lorazapam&amp;diff=27735&amp;oldid=prev"/>
		<updated>2020-11-13T13:53:15Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;====Lorazapam (ATIVAN) / Sedative Hypnotic==== &amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039; * It is a skeletal muscle relaxant that reduces tremors, induces amnesia, and reduces the incidence and recurr...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;====Lorazapam (ATIVAN) / Sedative Hypnotic====&lt;br /&gt;
'''DESCRIPTION'''&lt;br /&gt;
* It is a skeletal muscle relaxant that reduces tremors, induces amnesia, and reduces the incidence and recurrence of seizures.&lt;br /&gt;
'''INDICATIONS'''&lt;br /&gt;
* [[Seizure|Seizures]], [[Seizure|Status Epilepticus]], premedication prior to [[Cardioversion|cardioversion]], acute anxiety states, acute alcohol withdrawal.&lt;br /&gt;
'''CONTRAINDICATIONS'''&lt;br /&gt;
* Hypersensitivity to the medication, pregnancy, severe respiratory failure, acute narrow-angle glaucoma.&lt;br /&gt;
'''PRECAUTIONS'''&lt;br /&gt;
* Risk for respiratory depression and bradycardia, and should be administered with ECG SpO2 EtCO2 monitoring.&lt;br /&gt;
'''DOSAGE'''&lt;br /&gt;
* 1-2 mg Slow IVP for adults titrated to effect. Max dose of 8mg.  If no IV access or Agitated/Violent behavioral patient, administer 1-2 mg IM up to a total of 2 ml per large muscle injection site or 1 ml per small muscle injection site. &lt;br /&gt;
* Refer to Handtevy System for pediatric dosage.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Medication Guidelines|0815]]&lt;/div&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
</feed>